PT  - JOURNAL ARTICLE
AU  - Seviiri, Mathias
AU  - Law, Matthew H.
AU  - Ong, Jue-Sheng
AU  - Gharahkhani, Puya
AU  - Fontanillas, Pierre
AU  - ,
AU  - Olsen, Catherine M.
AU  - Whiteman, David C.
AU  - MacGregor, Stuart
TI  - A multi-phenotype analysis reveals 19 novel susceptibility loci for basal cell carcinoma and 15 for squamous cell carcinoma
AID  - 10.1101/2022.03.06.22271725
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.06.22271725
4099  - http://medrxiv.org/content/early/2022/03/08/2022.03.06.22271725.short
4100  - http://medrxiv.org/content/early/2022/03/08/2022.03.06.22271725.full
AB  - Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common forms of skin cancer. There is genetic overlap between skin cancers, pigmentation traits, and autoimmune diseases. We use linkage disequilibrium score regression to identify 20 traits (melanoma, pigmentation traits, autoimmune diseases, and blood biochemistry biomarkers) with a high genetic correlation (rg > 10%, P < 0.05) with BCC (20,791 cases and 286,893 controls in the UK Biobank) and SCC (7,402 cases and 286,892 controls in the UK Biobank), and use a multi-trait genetic analysis to identify 78 and 69 independent genome-wide significant (P < 5 × 10-8) susceptibility loci for BCC and SCC respectively; 19 BCC and 15 SCC loci are both novel and replicated (P < 0.05) in a large independent cohort; 23andMe, Inc (BCC: 251,963 cases and 2,271,667 controls, and SCC: 134,700 cases and 2,394,699 controls. Novel loci are implicated in BCC/SCC development and progression (e.g. CDKL1), pigmentation (e.g. DSTYK), cardiometabolic pathways (e.g. FADS2), and immune-regulatory pathways including; innate immunity against coronaviruses (e.g. IFIH1), and HIV-1 viral load modulation and disease progression (e.g. CCR5). We also report a powerful and optimised BCC polygenic risk score that enables effective risk stratification for keratinocyte cancer in a large prospective Canadian Longitudinal Study of Aging (794 cases and 18139 controls); e.g. percentage of participants reclassified; MTAGPRS = 36.57%, 95% CI = 35.89-37.26% versus UKBPRS= 33.23%, 95% CI=32.56-33.91%).Competing Interest StatementPierre Fontanillas, Chao Tian, and the 23andMe Research Team are employed by and hold stock or stock options in 23andMe, Inc. The rest of the authors declare no conflict of interests.Funding StatementThe study was supported by a program grant (APP1073898) and a project grant (APP1063061) from the Australian National Health and Medical Research Council (NHMRC). MS was supported by the Australian Government Research Training Program (RTP) and the Faculty of Health Scholarship at Queensland University of Technology, Australia. SM and DCW are supported by Research Fellowships from the NHMRC. This study was conducted using data from UK Biobank (application number 25331), QSkin Sun and Health Study (Australia), Canadian Longitudinal Study on Aging (CLSA), the 23andMe Research Team (USA), eMERGE (USA), GERA (USA) and other publicly available data from other consortia. We thank the research participants and the employees of 23andMe for making this work possible. The opinions expressed in this manuscript are the author's own and do not reflect the views of the Canadian Longitudinal Study on Aging or any affiliated institution. This research was made possible using the data/bio-specimens collected by the Canadian Longitudinal Study on Aging (CLSA). Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 94473 and the Canada Foundation for Innovation. This research has been conducted using the CLSA dataset [Baseline Comprehensive Dataset version 4.0, Follow-up 1 Comprehensive Dataset version 1.0], under Application Number 190225. The CLSA is led by Drs. Parminder Raina, Christina Wolfson and Susan Kirkland. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Research Ethics Committee of QIMR Berghofer Medical Research Institute gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGWAS summary statistics The full GWAS summary statistics for this study will be made available through the NHGRI-EBI GWAS Catalogue upon publication (https://www.ebi.ac.uk/gwas/downloads/summary-statistics). Polygenic risk scores The PRS developed and utilised in this study are provided in the Supplementary Tables 7 and 8. UK Biobank UK Biobank data is available through application via https://www.ukbiobank.ac.uk/. Information on UKB blood biochemistry biomarkers can be found in the UKB dataset: http://biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=17518 Canadian Longitudinal Study on Aging Data are available from the Canadian Longitudinal Study on Aging (www.clsa-elcv.ca) for researchers who meet the criteria for access to de-identified CLSA data. 23andMe The variant-level data for the 23andMe replication dataset are fully disclosed in the manuscript. dbGaP https://www.ncbi.nlm.nih.gov/gap/advanced_search/